Benjamin Halladay

Insider Reports History

Entity
Individual
Location
Esperion Therapeutics, Inc., 3891 Ranchero Drive, Suite 150, Ann Arbor, MI
Signature
/s/ Sheldon L. Koenig, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin Halladay:

Insider Reports Filed by Benjamin Halladay

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ESPR Esperion Therapeutics, Inc. Feb 19, 2025 1 -$21 4 Feb 20, 2025 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Jan 17, 2025 1 -$20 4 Jan 21, 2025 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Dec 17, 2024 1 -$7.87K 4 Dec 18, 2024 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2024 2 $0 4 Mar 15, 2024 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Mar 14, 2023 2 $0 4 Mar 15, 2023 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Dec 9, 2022 2 $0 4 Dec 12, 2022 Chief Financial Officer
ESPR Esperion Therapeutics, Inc. Nov 16, 2022 0 $0 3 Nov 16, 2022 Chief Financial Officer